| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.93 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |